PATHWAYS OF COAGULATION ACTIVATION INSITU IN RHEUMATOID SYNOVIAL TISSUE

被引:65
作者
ZACHARSKI, LR
BROWN, FE
MEMOLI, VA
KISIEL, W
KUDRYK, BJ
ROUSSEAU, SM
HUNT, JA
DUNWIDDIE, C
NUTT, EM
机构
[1] DARTMOUTH MED SCH, DEPT SURG, WHITE RIVER JCT, VT 05009 USA
[2] DARTMOUTH MED SCH, DEPT PATHOL, WHITE RIVER JCT, VT 05009 USA
[3] VET ADM MED CTR, WHITE RIVER JCT, VT 05009 USA
[4] UNIV NEW MEXICO, SCH MED, DEPT PATHOL, ALBUQUERQUE, NM 87131 USA
[5] NEW YORK BLOOD CTR, PLASMA PROT COAGULAT LAB, NEW YORK, NY 10021 USA
[6] MERCK SHARP & DOHME LTD, DEPT PHARMACOL, W POINT, PA 19486 USA
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1992年 / 63卷 / 02期
关键词
D O I
10.1016/0090-1229(92)90008-C
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunohistochemical techniques were applied to rheumatoid synovium in order to detect components of coagulation and fibrinolysis pathways within these tissues. These techniques revealed an intact coagulation pathway and plasminogen activator inhibitor-2 associated with macrophagelike cells that were present throughout these tissues, especially in subsurface areas. Cell-associated thrombin generation appeared to account for conversion of abundant fibrinogen to fibrin. Occasional macrophage-like cells also stained for urokinase but tissue-type plasminogen activator and plasminogen activator inhibitor-1 were restricted to vascular endothelium. Intense synovial fibrin deposition (with the limited evidence for associated fibrinolysis) may contribute to local inflammation and explain certain clinical features of rheumatoid arthritis. These findings suggest novel treatment hypotheses for this disease. © 1992.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 63 条
  • [51] STUMP DC, 1986, J BIOL CHEM, V261, P1267
  • [52] STUMP DC, 1986, J BIOL CHEM, V261, P7120
  • [53] ACTIVATORS AND INHIBITORS OF FIBRINOLYSIS IN RHEUMATOID AND NON-RHEUMATOID SYNOVIAL MEMBRANES - HISTOCHEMICAL STUDY
    VANDEPUTTE, LBA
    HEGT, VN
    OVERBEEK, TE
    [J]. ARTHRITIS AND RHEUMATISM, 1977, 20 (02): : 671 - 678
  • [54] CONCOMITANT SECRETION OF PROUROKINASE AND OF A PLASMINOGEN-ACTIVATOR SPECIFIC INHIBITOR BY CULTURED HUMAN MONOCYTES-MACROPHAGES
    VASSALLI, JD
    DAYER, JM
    WOHLWEND, A
    BELIN, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 159 (06) : 1653 - 1668
  • [55] MODULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR MESSENGER-RNA LEVELS IN HUMAN SYNOVIAL FIBROBLASTS BY INTERLEUKIN-1, RETINOIC ACID, AND A GLUCOCORTICOID
    VITTI, G
    HAMILTON, JA
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (08): : 1046 - 1051
  • [56] ENDOGENOUS ACTIVATION OF LATENT COLLAGENASE BY RHEUMATOID SYNOVIAL CELLS - EVIDENCE FOR A ROLE OF PLASMINOGEN ACTIVATOR
    WERB, Z
    MAINARDI, CL
    VATER, CA
    HARRIS, ED
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (18) : 1017 - 1023
  • [57] LOCALIZATION OF TISSUE FACTOR IN THE NORMAL VESSEL WALL AND IN THE ATHEROSCLEROTIC PLAQUE
    WILCOX, JN
    SMITH, KM
    SCHWARTZ, SM
    GORDON, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) : 2839 - 2843
  • [58] WOJTUKIEWICZ MZ, 1990, ANTICANCER RES, V10, P579
  • [59] WOJTUKIEWICZ MZ, 1990, CANCER, V65, P481, DOI 10.1002/1097-0142(19900201)65:3<481::AID-CNCR2820650318>3.0.CO
  • [60] 2-U